Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PureTech Health plc (PRTC) Invested Capital (2019 - 2023)

PureTech Health (PRTC) has disclosed Invested Capital for 3 consecutive years, with $645.3 million as the latest value for Q4 2022.

  • On a quarterly basis, Invested Capital rose 6.03% to $645.3 million in Q4 2022 year-over-year; TTM through Dec 2022 was $645.3 million, a 6.03% increase, with the full-year FY2022 number at $645.3 million, up 6.03% from a year prior.
  • Invested Capital was $645.3 million for Q4 2022 at PureTech Health, up from $608.6 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $684.6 million in Q4 2020 to a low of $608.6 million in Q4 2021.
  • A 3-year average of $646.2 million and a median of $645.3 million in 2022 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: dropped 11.09% in 2021, then grew 6.03% in 2022.
  • PureTech Health's Invested Capital stood at $684.6 million in 2020, then dropped by 11.09% to $608.6 million in 2021, then rose by 6.03% to $645.3 million in 2022.
  • Per Business Quant, the three most recent readings for PRTC's Invested Capital are $645.3 million (Q4 2022), $608.6 million (Q4 2021), and $684.6 million (Q4 2020).